Actemra (Tocilizumab) Utilization Among Pregnant Women

Project Title Actemra (Tocilizumab) Utilization Among Pregnant Women
Date Posted
Tuesday, July 18, 2017
Project ID
cder_mpl1r_wp049_nsdp_v01
Status
Complete
Deliverables
Description

This report contains estimates of tocilizumab use that occurred during a pregnancy resulting in a liveborn delivery, or within 90 days prior to the estimated start of pregnancy. This query request was distributed to 16 Data Partners on February 9, 2017, and requested data that spanned from the time period of January 1, 2010 to Septemeber 30, 2015.

Medical Product
Actemra
tocilizumab
Health Outcome
juvenile rheumatoid arthritis
rheumatoid arthritis
Population / Cohort
All females 15 - 54 years of age with a live birth between January 2010 - December 2015
Time Period
2010 - 2015
Assessment Type
Exploratory Analyses
Study Type
Modular Program
FDA Center
CDER